Covid-19 vaccine

Vaxzevria

BrazilCancelledAuthorised 12 Mar 2021

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca)European Union · AstraZeneca ABSame brand
BimervaxEuropean Union · Hipra Human Health S.L.Same form
NuvaxovidEuropean Union · Sanofi Winthrop IndustrieSame form
Comirnaty (LP.8.1)New Zealand · Inj 3 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, 0.48 ml multi-dose vial; infant vaccine, yellow capSame substance
Comirnaty (LP.8.1)New Zealand · Inj 30 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, pre-filled syringe; adult doseSame substance
Comirnaty (LP.8.1)

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Covid-19 vaccine

Vaxzevria

BrazilCancelledAuthorised 12 Mar 2021

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

New Zealand · Inj 10 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, 0.48 ml single-dose vial; paediatric vaccine, light blue cap

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Covid-19 vaccine
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 12 Mar 2021
Registration: 116180284
Marketing authorisation holder: Astrazeneca do Brasil Ltda
ATC code: J07
Group: Anti-infectives for systemic use
Procedure: Registered

Anvisa

Vacina Covid-19 (Recombinante)Covid-19 vaccineBrazil

Vacina COVID-19 (recombinante)Covid-19 vaccineBrazil

SpikevaxCovid-19 vaccineBrazilCancelled

vacina covid-19 (recombinante)Covid-19 vaccineBrazilCancelled